Anja Schweizer

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial.

Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial.

Journal: The lancet. Diabetes & endocrinology

Published: August 25, 2025

Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT-HF registry.

Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT-HF registry.

Journal: European journal of heart failure

Published: July 16, 2025

Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial.

Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial.

Journal: Circulation

Published: May 20, 2025

Quality of care delivery in patients with acute heart failure: insights from the international REPORT-HF registry.

Quality of care delivery in patients with acute heart failure: insights from the international REPORT-HF registry.

Journal: EClinicalMedicine

Published: September 15, 2024

Prognostic Implications and Global Perspectives of Atrial Fibrillation in Patients Hospitalized for Heart Failure.

Prognostic Implications and Global Perspectives of Atrial Fibrillation in Patients Hospitalized for Heart Failure.

Journal: JACC. Heart failure

Published: May 31, 2024

Hospitalized Advanced Heart Failure With Preserved vs Reduced Left Ventricular Ejection Fraction: A Global Perspective.

Hospitalized Advanced Heart Failure With Preserved vs Reduced Left Ventricular Ejection Fraction: A Global Perspective.

Journal: JACC. Heart failure

Published: April 29, 2024

Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study.

Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study.

Journal: The Lancet. Global health

Published: April 19, 2023

Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry.

Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry.

Journal: JACC. Heart failure

Published: April 12, 2023

Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.

Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.

Journal: European journal of heart failure

Published: November 09, 2022

Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF.

Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF.

Journal: European journal of heart failure

Published: June 13, 2022

Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure).

Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure).

Journal: European journal of heart failure

Published: December 05, 2021

Rationale and design of two trials assessing the efficacy, safety, and tolerability of inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia.

Rationale and design of two trials assessing the efficacy, safety, and tolerability of inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia.

Journal: European journal of preventive cardiology

Published: November 17, 2021

Showing 1-12 of 45

Last Updated: 09/26/2026